{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T15:53:09Z","timestamp":1795189989694,"version":"4.10.3"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["702\/13"],"award-info":[{"award-number":["702\/13"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["702\/13"],"award-info":[{"award-number":["702\/13"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["702\/13"],"award-info":[{"award-number":["702\/13"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mutations in\n                    <jats:italic>Vaccinia-related kinase 1<\/jats:italic>\n                    (\n                    <jats:italic>VRK1<\/jats:italic>\n                    ) have emerged as a cause of severe neuronal phenotypes in human, including brain developmental defects and degeneration of spinal motor neurons, leading to Spinal Muscular Atrophy (SMA) or early onset Amyotrophic Lateral Sclerosis (ALS). Vrk1 gene-trap partial Knockout (KO) mice (Vrk1\n                    <jats:sup>GT3\/GT3<\/jats:sup>\n                    ), which express decreased levels of\n                    <jats:italic>Vrk1<\/jats:italic>\n                    , are sterile due to impaired gamete production. Here, we examined whether this mouse model also presents neuronal phenotypes. We found a 20\u201350% reduction in\n                    <jats:italic>Vrk1<\/jats:italic>\n                    expression in neuronal tissues of the Vrk1\n                    <jats:sup>GT3\/GT3<\/jats:sup>\n                    mice, leading to mild neuronal phenotypes including significant but small reduction in brain mass and motor (rotarod) impairment. Analysis of gene expression in the Vrk1\n                    <jats:sup>GT3\/GT3<\/jats:sup>\n                    cortex predicts novel roles for VRK1 in neuronal pathways including neurotrophin signaling, axon guidance and pathways implicated in the pathogenesis of ALS. Together, our studies of the partial KO Vrk1 mice reveal that even moderately reduced levels of Vrk1 expression result in minor neurological impairment and indicate new neuronal pathways likely involving VRK1.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-29215-x","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T05:32:56Z","timestamp":1532064776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Vrk1 partial Knockdown in Mice Results in Reduced Brain Weight and Mild Motor Dysfunction, and Indicates Neuronal VRK1 Target Pathways"],"prefix":"10.1038","volume":"8","author":[{"given":"Hadar","family":"Vinograd-Byk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Renbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrat","family":"Levy-Lahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"key":"29215_CR1","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.cellsig.2011.04.002","volume":"23","author":"A Valbuena","year":"2011","unstructured":"Valbuena, A., Sanz-Garcia, M., Lopez-Sanchez, I., Vega, F. M. & Lazo, P. A. Roles of VRK1 as a new player in the control of biological processes required for cell division. Cellular signalling 23, 1267\u20131272, https:\/\/doi.org\/10.1016\/j.cellsig.2011.04.002 (2011).","journal-title":"Cellular signalling"},{"key":"29215_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.febslet.2014.01.040","volume":"588","author":"I Lopez-Sanchez","year":"2014","unstructured":"Lopez-Sanchez, I. et al. VRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damage. FEBS letters 588, 692\u2013700, https:\/\/doi.org\/10.1016\/j.febslet.2014.01.040 (2014).","journal-title":"FEBS letters"},{"key":"29215_CR3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbamcr.2016.02.005","volume":"1863","author":"DM Monsalve","year":"2016","unstructured":"Monsalve, D. M. et al. VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damage. Biochimica et biophysica acta 1863, 760\u2013769, https:\/\/doi.org\/10.1016\/j.bbamcr.2016.02.005 (2016).","journal-title":"Biochimica et biophysica acta"},{"key":"29215_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/srep28532","volume":"6","author":"DS Moura","year":"2016","unstructured":"Moura, D. S. et al. Oncogenic Sox2 regulates and cooperates with VRK1 in cell cycle progression and differentiation. Scientific reports 6, 28532, https:\/\/doi.org\/10.1038\/srep28532 (2016).","journal-title":"Scientific reports"},{"key":"29215_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/15592294.2015.1028708","volume":"10","author":"M Salzano","year":"2015","unstructured":"Salzano, M., Sanz-Garcia, M., Monsalve, D. M., Moura, D. S. & Lazo, P. A. VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage. Epigenetics 10, 373\u2013383, https:\/\/doi.org\/10.1080\/15592294.2015.1028708 (2015).","journal-title":"Epigenetics"},{"key":"29215_CR6","doi-asserted-by":"publisher","first-page":"23757","DOI":"10.1074\/jbc.M112.353102","volume":"287","author":"M Sanz-Garcia","year":"2012","unstructured":"Sanz-Garcia, M., Monsalve, D. M., Sevilla, A. & Lazo, P. A. Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage. The Journal of biological chemistry 287, 23757\u201323768, https:\/\/doi.org\/10.1074\/jbc.M112.353102 (2012).","journal-title":"The Journal of biological chemistry"},{"key":"29215_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ajhg.2009.07.006","volume":"85","author":"P Renbaum","year":"2009","unstructured":"Renbaum, P. et al. Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene. American journal of human genetics 85, 281\u2013289, https:\/\/doi.org\/10.1016\/j.ajhg.2009.07.006 (2009).","journal-title":"American journal of human genetics"},{"key":"29215_CR8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1523\/JNEUROSCI.1998-14.2015","volume":"35","author":"H Vinograd-Byk","year":"2015","unstructured":"Vinograd-Byk, H. et al. The spinal muscular atrophy with pontocerebellar hypoplasia gene VRK1 regulates neuronal migration through an amyloid-beta precursor protein-dependent mechanism. The Journal of neuroscience: the official journal of the Society for Neuroscience 35, 936\u2013942, https:\/\/doi.org\/10.1523\/JNEUROSCI.1998-14.2015 (2015).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"29215_CR9","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/jamaneurol.2013.4598","volume":"70","author":"C Gonzaga-Jauregui","year":"2013","unstructured":"Gonzaga-Jauregui, C. et al. Mutations in VRK1 associated with complex motor and sensory axonal neuropathy plus microcephaly. JAMA neurology 70, 1491\u20131498, https:\/\/doi.org\/10.1001\/jamaneurol.2013.4598 (2013).","journal-title":"JAMA neurology"},{"key":"29215_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature10423","volume":"478","author":"H Najmabadi","year":"2011","unstructured":"Najmabadi, H. et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 478, 57\u201363, https:\/\/doi.org\/10.1038\/nature10423 (2011).","journal-title":"Nature"},{"key":"29215_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1212\/WNL.0000000000002813","volume":"87","author":"M Stoll","year":"2016","unstructured":"Stoll, M. et al. Novel motor phenotypes in patients with VRK1 mutations without pontocerebellar hypoplasia. Neurology 87, 65\u201370, https:\/\/doi.org\/10.1212\/WNL.0000000000002813 (2016).","journal-title":"Neurology"},{"key":"29215_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/CND.0000000000000096","volume":"17","author":"TP Nguyen","year":"2015","unstructured":"Nguyen, T. P., Biliciler, S., Wiszniewski, W. & Sheikh, K. Expanding Phenotype of VRK1 Mutations in Motor Neuron Disease. Journal of clinical neuromuscular disease 17, 69\u201371, https:\/\/doi.org\/10.1097\/CND.0000000000000096 (2015).","journal-title":"Journal of clinical neuromuscular disease"},{"key":"29215_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1095\/biolreprod.109.079095","volume":"82","author":"MS Wiebe","year":"2010","unstructured":"Wiebe, M. S., Nichols, R. J., Molitor, T. P., Lindgren, J. K. & Traktman, P. Mice deficient in the serine\/threonine protein kinase VRK1 are infertile due to a progressive loss of spermatogonia. Biology of reproduction 82, 182\u2013193, https:\/\/doi.org\/10.1095\/biolreprod.109.079095 (2010).","journal-title":"Biology of reproduction"},{"key":"29215_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.mod.2011.01.004","volume":"128","author":"CS Schober","year":"2011","unstructured":"Schober, C. S., Aydiner, F., Booth, C. J., Seli, E. & Reinke, V. The kinase VRK1 is required for normal meiotic progression in mammalian oogenesis. Mechanisms of development 128, 178\u2013190, https:\/\/doi.org\/10.1016\/j.mod.2011.01.004 (2011).","journal-title":"Mechanisms of development"},{"key":"29215_CR15","doi-asserted-by":"publisher","first-page":"e15254","DOI":"10.1371\/journal.pone.0015254","volume":"5","author":"YH Choi","year":"2010","unstructured":"Choi, Y. H. et al. Vaccinia-related kinase 1 is required for the maintenance of undifferentiated spermatogonia in mouse male germ cells. PloS one 5, e15254, https:\/\/doi.org\/10.1371\/journal.pone.0015254 (2010).","journal-title":"PloS one"},{"key":"29215_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep00468","volume":"2","author":"J Kim","year":"2012","unstructured":"Kim, J., Choi, Y. H., Chang, S., Kim, K. T. & Je, J. H. Defective folliculogenesis in female mice lacking Vaccinia-related kinase 1. Scientific reports 2, 468, https:\/\/doi.org\/10.1038\/srep00468 (2012).","journal-title":"Scientific reports"},{"key":"29215_CR17","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419, https:\/\/doi.org\/10.1126\/science.1260419 (2015).","journal-title":"Science"},{"key":"29215_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1006\/geno.1997.4938","volume":"45","author":"J Nezu","year":"1997","unstructured":"Nezu, J., Oku, A., Jones, M. H. & Shimane, M. Identification of two novel human putative serine\/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics 45, 327\u2013331 (1997).","journal-title":"Genomics"},{"key":"29215_CR19","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102, 15545\u201315550, https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"29215_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fncel.2015.00056","volume":"9","author":"G Kreiner","year":"2015","unstructured":"Kreiner, G. Compensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans? Frontiers in cellular neuroscience 9, 56, https:\/\/doi.org\/10.3389\/fncel.2015.00056 (2015).","journal-title":"Frontiers in cellular neuroscience"},{"key":"29215_CR21","doi-asserted-by":"publisher","first-page":"7934","DOI":"10.1074\/jbc.M310813200","volume":"279","author":"RJ Nichols","year":"2004","unstructured":"Nichols, R. J. & Traktman, P. Characterization of three paralogous members of the Mammalian vaccinia related kinase family. The Journal of biological chemistry 279, 7934\u20137946, https:\/\/doi.org\/10.1074\/jbc.M310813200 (2004).","journal-title":"The Journal of biological chemistry"},{"key":"29215_CR22","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1111\/j.1742-4658.2006.05256.x","volume":"273","author":"S Blanco","year":"2006","unstructured":"Blanco, S., Klimcakova, L., Vega, F. M. & Lazo, P. A. The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines. The FEBS journal 273, 2487\u20132504, https:\/\/doi.org\/10.1111\/j.1742-4658.2006.05256.x (2006).","journal-title":"The FEBS journal"},{"key":"29215_CR23","doi-asserted-by":"publisher","first-page":"e2649","DOI":"10.1371\/journal.pone.0002649","volume":"3","author":"A Valbuena","year":"2008","unstructured":"Valbuena, A., Blanco, S., Vega, F. M. & Lazo, P. A. The C\/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53. PloS one 3, e2649, https:\/\/doi.org\/10.1371\/journal.pone.0002649 (2008).","journal-title":"PloS one"},{"key":"29215_CR24","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1038\/sj.onc.1203709","volume":"19","author":"S Lopez-Borges","year":"2000","unstructured":"Lopez-Borges, S. & Lazo, P. A. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein. Oncogene 19, 3656\u20133664, https:\/\/doi.org\/10.1038\/sj.onc.1203709 (2000).","journal-title":"Oncogene"},{"key":"29215_CR25","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1091\/mbc.e05-12-1179","volume":"17","author":"RJ Nichols","year":"2006","unstructured":"Nichols, R. J., Wiebe, M. S. & Traktman, P. The vaccinia-related kinases phosphorylate the N\u2032 terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Molecular biology of the cell 17, 2451\u20132464, https:\/\/doi.org\/10.1091\/mbc.E05-12-1179 (2006).","journal-title":"Molecular biology of the cell"},{"key":"29215_CR26","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.bbamcr.2015.04.007","volume":"1853","author":"CH Park","year":"2015","unstructured":"Park, C. H. et al. Presumed pseudokinase VRK3 functions as a BAF kinase. Biochimica et biophysica acta 1853, 1738\u20131748, https:\/\/doi.org\/10.1016\/j.bbamcr.2015.04.007 (2015).","journal-title":"Biochimica et biophysica acta"},{"key":"29215_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ajmg.c.31397","volume":"166C","author":"D Alcantara","year":"2014","unstructured":"Alcantara, D. & O\u2019Driscoll, M. Congenital microcephaly. American journal of medical genetics. Part C, Seminars in medical genetics 166C, 124\u2013139, https:\/\/doi.org\/10.1002\/ajmg.c.31397 (2014).","journal-title":"Part C, Seminars in medical genetics"},{"key":"29215_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/wdev.89","volume":"2","author":"EC Gilmore","year":"2013","unstructured":"Gilmore, E. C. & Walsh, C. A. Genetic causes of microcephaly and lessons for neuronal development. Wiley interdisciplinary reviews. Developmental biology 2, 461\u2013478, https:\/\/doi.org\/10.1002\/wdev.89 (2013).","journal-title":"Wiley interdisciplinary reviews. Developmental biology"},{"key":"29215_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/sj.neo.7900200","volume":"4","author":"D Fults","year":"2002","unstructured":"Fults, D., Pedone, C., Dai, C. & Holland, E. C. MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo. Neoplasia 4, 32\u201339, https:\/\/doi.org\/10.1038\/sj\/neo\/7900200 (2002).","journal-title":"Neoplasia"},{"key":"29215_CR30","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1242\/jcs.024802","volume":"121","author":"L Kerosuo","year":"2008","unstructured":"Kerosuo, L. et al. Myc increases self-renewal in neural progenitor cells through Miz-1. Journal of cell science 121, 3941\u20133950, https:\/\/doi.org\/10.1242\/jcs.024802 (2008).","journal-title":"Journal of cell science"},{"key":"29215_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1042\/BJ20112040","volume":"444","author":"C Hindley","year":"2012","unstructured":"Hindley, C. & Philpott, A. Co-ordination of cell cycle and differentiation in the developing nervous system. The Biochemical journal 444, 375\u2013382, https:\/\/doi.org\/10.1042\/BJ20112040 (2012).","journal-title":"The Biochemical journal"},{"key":"29215_CR32","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1128\/MCB.00378-10","volume":"31","author":"MG Andrusiak","year":"2011","unstructured":"Andrusiak, M. G. et al. Rb\/E2F regulates expression of neogenin during neuronal migration. Molecular and cellular biology 31, 238\u2013247, https:\/\/doi.org\/10.1128\/MCB.00378-10 (2011).","journal-title":"Molecular and cellular biology"},{"key":"29215_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.bbadis.2006.12.003","volume":"1772","author":"LA Greene","year":"2007","unstructured":"Greene, L. A., Liu, D. X., Troy, C. M. & Biswas, S. C. Cell cycle molecules define a pathway required for neuron death in development and disease. Biochimica et biophysica acta 1772, 392\u2013401, https:\/\/doi.org\/10.1016\/j.bbadis.2006.12.003 (2007).","journal-title":"Biochimica et biophysica acta"},{"key":"29215_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pneurobio.2011.04.013","volume":"94","author":"DK Jeppesen","year":"2011","unstructured":"Jeppesen, D. K., Bohr, V. A. & Stevnsner, T. DNA repair deficiency in neurodegeneration. Progress in neurobiology 94, 166\u2013200, https:\/\/doi.org\/10.1016\/j.pneurobio.2011.04.013 (2011).","journal-title":"Progress in neurobiology"},{"key":"29215_CR35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.neuron.2014.06.034","volume":"83","author":"R Madabhushi","year":"2014","unstructured":"Madabhushi, R., Pan, L. & Tsai, L. H. DNA damage and its links to neurodegeneration. Neuron 83, 266\u2013282, https:\/\/doi.org\/10.1016\/j.neuron.2014.06.034 (2014).","journal-title":"Neuron"},{"key":"29215_CR36","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1098\/rstb.2006.1894","volume":"361","author":"LF Reichardt","year":"2006","unstructured":"Reichardt, L. F. Neurotrophin-regulated signalling pathways. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 361, 1545\u20131564, https:\/\/doi.org\/10.1098\/rstb.2006.1894 (2006).","journal-title":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences"},{"key":"29215_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2990.2003.00487.x","volume":"29","author":"D Dawbarn","year":"2003","unstructured":"Dawbarn, D. & Allen, S. J. Neurotrophins and neurodegeneration. Neuropathology and applied neurobiology 29, 211\u2013230 (2003).","journal-title":"Neuropathology and applied neurobiology"},{"key":"29215_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/B978-0-12-385883-2.00002-3","volume":"107","author":"RL Redler","year":"2012","unstructured":"Redler, R. L. & Dokholyan, N. V. The complex molecular biology of amyotrophic lateral sclerosis (ALS). Progress in molecular biology and translational science 107, 215\u2013262, https:\/\/doi.org\/10.1016\/B978-0-12-385883-2.00002-3 (2012).","journal-title":"Progress in molecular biology and translational science"},{"key":"29215_CR39","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1042\/BST0350424","volume":"35","author":"A Hennigan","year":"2007","unstructured":"Hennigan, A., O\u2019Callaghan, R. M. & Kelly, A. M. Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochemical Society transactions 35, 424\u2013427, https:\/\/doi.org\/10.1042\/BST0350424 (2007).","journal-title":"Biochemical Society transactions"},{"key":"29215_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1468-1331.1998.550487.x","volume":"5","author":"HJ Stuerenburg","year":"1998","unstructured":"Stuerenburg, H. J. & Kunze, K. Tissue nerve growth factor concentrations in neuromuscular diseases. European journal of neurology 5, 487\u2013490 (1998).","journal-title":"European journal of neurology"},{"key":"29215_CR41","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1023\/A:1007575504321","volume":"25","author":"T Mutoh","year":"2000","unstructured":"Mutoh, T. et al. Decreased phosphorylation levels of TrkB neurotrophin receptor in the spinal cords from patients with amyotrophic lateral sclerosis. Neurochemical research 25, 239\u2013245 (2000).","journal-title":"Neurochemical research"},{"key":"29215_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/exnr.2002.8011","volume":"177","author":"BM Kust","year":"2002","unstructured":"Kust, B. M., Copray, J. C., Brouwer, N., Troost, D. & Boddeke, H. W. Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Experimental neurology 177, 419\u2013427 (2002).","journal-title":"Experimental neurology"},{"key":"29215_CR43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ana.20379","volume":"57","author":"YM Jiang","year":"2005","unstructured":"Jiang, Y. M. et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Annals of neurology 57, 236\u2013251, https:\/\/doi.org\/10.1002\/ana.20379 (2005).","journal-title":"Annals of neurology"},{"key":"29215_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0022-510X(98)00333-5","volume":"162","author":"E Grundstrom","year":"1999","unstructured":"Grundstrom, E. et al. Increased expression of glial cell line-derived neurotrophic factor mRNA in muscle biopsies from patients with amyotrophic lateral sclerosis. Journal of the neurological sciences 162, 169\u2013173 (1999).","journal-title":"Journal of the neurological sciences"},{"key":"29215_CR45","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1023\/A:1020739831778","volume":"24","author":"M Yamamoto","year":"1999","unstructured":"Yamamoto, M. et al. Expression of GDNF and GDNFR-alpha mRNAs in muscles of patients with motor neuron diseases. Neurochemical research 24, 785\u2013790 (1999).","journal-title":"Neurochemical research"},{"key":"29215_CR46","unstructured":"Renbaum, P., Zeligson, S., Levy-Lahad, E. & Vinograd-Byk, H. Gene expression profiling in a VRK1 R358X homozygote patient. Gene Expression Omnibus (GEO) (2015). GEO accession: GSE66061."},{"key":"29215_CR47","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.pneurobio.2009.05.004","volume":"88","author":"ER Schmidt","year":"2009","unstructured":"Schmidt, E. R., Pasterkamp, R. J. & van den Berg, L. H. Axon guidance proteins: novel therapeutic targets for ALS? Progress in neurobiology 88, 286\u2013301, https:\/\/doi.org\/10.1016\/j.pneurobio.2009.05.004 (2009).","journal-title":"Progress in neurobiology"},{"key":"29215_CR48","doi-asserted-by":"publisher","first-page":"e1449","DOI":"10.1371\/journal.pone.0001449","volume":"3","author":"TG Lesnick","year":"2008","unstructured":"Lesnick, T. G. et al. Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway. PloS one 3, e1449, https:\/\/doi.org\/10.1371\/journal.pone.0001449 (2008).","journal-title":"PloS one"},{"key":"29215_CR49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fnins.2014.00252","volume":"8","author":"EB Moloney","year":"2014","unstructured":"Moloney, E. B., de Winter, F. & Verhaagen, J. ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Frontiers in neuroscience 8, 252, https:\/\/doi.org\/10.3389\/fnins.2014.00252 (2014).","journal-title":"Frontiers in neuroscience"},{"key":"29215_CR50","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pneurobio.2016.05.004","volume":"142","author":"M Zufiria","year":"2016","unstructured":"Zufiria, M. et al. ALS: A bucket of genes, environment, metabolism and unknown ingredients. Progress in neurobiology 142, 104\u2013129, https:\/\/doi.org\/10.1016\/j.pneurobio.2016.05.004 (2016).","journal-title":"Progress in neurobiology"},{"key":"29215_CR51","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1172\/JCI82693","volume":"125","author":"OM Peters","year":"2015","unstructured":"Peters, O. M., Ghasemi, M. & Brown, R. H. Jr. Emerging mechanisms of molecular pathology in ALS. The Journal of clinical investigation 125, 2548, https:\/\/doi.org\/10.1172\/JCI82693 (2015).","journal-title":"The Journal of clinical investigation"},{"key":"29215_CR52","doi-asserted-by":"publisher","first-page":"506","DOI":"10.2174\/138920211797904043","volume":"12","author":"A Henriques","year":"2011","unstructured":"Henriques, A. & Gonzalez De Aguilar, J. L. Can transcriptomics cut the gordian knot of amyotrophic lateral sclerosis? Current genomics 12, 506\u2013515, https:\/\/doi.org\/10.2174\/138920211797904043 (2011).","journal-title":"Current genomics"},{"key":"29215_CR53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fncel.2013.00259","volume":"7","author":"PR Heath","year":"2013","unstructured":"Heath, P. R., Kirby, J. & Shaw, P. J. Investigating cell death mechanisms in amyotrophic lateral sclerosis using transcriptomics. Frontiers in cellular neuroscience 7, 259, https:\/\/doi.org\/10.3389\/fncel.2013.00259 (2013).","journal-title":"Frontiers in cellular neuroscience"},{"key":"29215_CR54","doi-asserted-by":"publisher","unstructured":"Smith, E. F., Shaw, P. J. & De Vos, K. J. The role of mitochondria in amyotrophic lateral sclerosis. Neuroscience letters, https:\/\/doi.org\/10.1016\/j.neulet.2017.06.052 (2017).","DOI":"10.1016\/j.neulet.2017.06.052"},{"key":"29215_CR55","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s12017-014-8321-y","volume":"16","author":"AC Ladd","year":"2014","unstructured":"Ladd, A. C., Keeney, P. M., Govind, M. M. & Bennett, J. P. Jr. Mitochondrial oxidative phosphorylation transcriptome alterations in human amyotrophic lateral sclerosis spinal cord and blood. Neuromolecular medicine 16, 714\u2013726, https:\/\/doi.org\/10.1007\/s12017-014-8321-y (2014).","journal-title":"Neuromolecular medicine"},{"key":"29215_CR56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1242\/dmm.015719","volume":"7","author":"SA Patten","year":"2014","unstructured":"Patten, S. A. et al. Fishing for causes and cures of motor neuron disorders. Disease models & mechanisms 7, 799\u2013809, https:\/\/doi.org\/10.1242\/dmm.015719 (2014).","journal-title":"Disease models & mechanisms"},{"key":"29215_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jnc.13945","volume":"141","author":"M Gama-Carvalho","year":"2017","unstructured":"Gama-Carvalho, M. et al. Linking amyotrophic lateral sclerosis and spinal muscular atrophy through RNA-transcriptome homeostasis: a genomics perspective. Journal of neurochemistry 141, 12\u201330, https:\/\/doi.org\/10.1111\/jnc.13945 (2017).","journal-title":"Journal of neurochemistry"},{"key":"29215_CR58","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1093\/hmg\/ddw262","volume":"25","author":"N Miller","year":"2016","unstructured":"Miller, N., Shi, H., Zelikovich, A. S. & Ma, Y. C. Motor neuron mitochondrial dysfunction in spinal muscular atrophy. Human molecular genetics 25, 3395\u20133406, https:\/\/doi.org\/10.1093\/hmg\/ddw262 (2016).","journal-title":"Human molecular genetics"},{"key":"29215_CR59","doi-asserted-by":"publisher","unstructured":"Hensel, N. & Claus, P. The Actin Cytoskeleton in SMA and ALS: How Does It Contribute to Motoneuron Degeneration? The Neuroscientist: a review journal bringing neurobiology, neurology and psychiatry, 1073858417705059, https:\/\/doi.org\/10.1177\/1073858417705059 (2017).","DOI":"10.1177\/1073858417705059"},{"key":"29215_CR60","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1038\/nprot.2006.275","volume":"1","author":"J Alamed","year":"2006","unstructured":"Alamed, J., Wilcock, D. M., Diamond, D. M., Gordon, M. N. & Morgan, D. Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice. Nature protocols 1, 1671\u20131679, https:\/\/doi.org\/10.1038\/nprot.2006.275 (2006).","journal-title":"Nature protocols"},{"key":"29215_CR61","doi-asserted-by":"publisher","first-page":"D710","DOI":"10.1093\/nar\/gkv1157","volume":"44","author":"A Yates","year":"2016","unstructured":"Yates, A. et al. Ensembl 2016. Nucleic acids research 44, D710\u2013716, https:\/\/doi.org\/10.1093\/nar\/gkv1157 (2016).","journal-title":"Nucleic acids research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29215-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29215-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29215-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:57:17Z","timestamp":1671591437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29215-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29215"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29215-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,26]]},"assertion":[{"value":"16 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11265"}}